Santa Clara, CA 6/25/12—Microarray firm Affymetrix has completed its $315 million purchase of eBioscience, a provider of flow cytometry and immunoassay reagents for immunology and oncology research and diagnostics (see IBO 5/15/12). “Through the acquisition of eBio we now have a blue-chip portfolio of cell-based assays that diversify our business and open up important new […]
Madison, WI 6/1/12; Aarau, Switzerland 6/10/12—Following a report in the Wisconsin State Journal, Roche has confirmed with IBO that it plans to eliminate product lines and lay off employees at Roche NimbleGen, a provider of DNA microarray technology. “Our Microarray portfolio will be streamlined and focused on our Sequence Capture products. All other microarray products […]
In fiscal 2011 (FY11), productivity growth for 19 major publicly held lab instrument and product companies (see table, page 6) slowed to 2.6%, compared with 4.7% in fiscal 2010. The slower growth, as measured by average sales per employee, was due to a jump in employment as a result of acquisitions and investments in emerging […]
OEM agreements are a well-established part of the instrument and lab product industry. With the growing need for cost savings and faster product introductions, the use of OEM agreements is increasing. Such agreements enable partner companies to concentrate on their areas of expertise and more efficiently allocate resources. For OEM suppliers, the agreements allow for […]
Company Announcements In March, a Delaware District Court consolidated shareholders’ class action suits against Illumina’s Board, alleging breach of fiduciary duties in connection with Roche’s tender offer (see IBO 1/31/12). In February, Waters acquired the net assets of its Israeli sales and service distributor for $6 million in cash. DKSH, a provider of market expansion […]
First-quarter Life Science Index sales grew 3.1%, 2.5% on a currency-neutral basis, to $3,163 million. Revenue growth for several companies was negatively impacted by lower research funding in the US. Operating profit improved 5.2% to $700 million, and operating margin was unchanged at 22.1% of sales. Of the 13 Index companies, Tecan was the only […]
Greece has set the stage for a modern-era economic tragedy, as the country decides whether to abide by the bailout agreement or exit the Eurozone. An even graver concern is the fate of other European debt-ridden countries. These concerns coupled with softer US manufacturing growth, declining US consumer confidence and continued weakness in the US […]
Crawley, UK 5/10/12; Crawley, UK 5/29/12—Vacuum product company Edwards Group began trading its shares on the NASDAQ Global Select Market on May 11 with 12.5 million shares at a price of $8.00 each (see IBO 3/31/12). The company reported net primary proceeds of $87.1 million, which were used to repay a tranche of debt under […]
Sales growth in developing economies, industrial markets and applied applications offset weakness in US and European academic and government markets in the calendar-year first quarter, according to the financial results of major, publicly held laboratory instrument and lab product businesses. For the eight businesses whose quarterly results are detailed on pages 9–11, total revenues for […]
First-quarter revenue growth for IBO’s Laboratory Instrument Sales Index slowed to 2.4%, 2.6% excluding currency, to $5,784 million. Operating profit climbed 8.4% to $1,251 million, and operating margin fell 90 basis points to 18.3% of sales. Financial estimates are included for Oxford Instruments, Spectris and Tecan, which have not yet reported first-quarter financial data. QIAGEN […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
